PET imaging of tau proteins with a novel radiotracer based on fluorine-18 (F-18) is showing great promise in differentiating between Alzheimer’s patients and cognitively normal individuals and identifying how the disease may develop, according to a study published online July 25 in JAMA Neurology. {read more here}